QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)

Flexion Therapeutics (FLXN) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
morningstar.com logoSpyre Therapeutics Inc SYRE
morningstar.com - February 14 at 2:31 AM
benzinga.com logoPFIZER INC's Net Worth
benzinga.com - February 10 at 6:39 PM
benzinga.com logoSpringWorks Therapeutics Stock (NASDAQ:SWTX), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 24 at 2:18 PM
benzinga.com logoFlexion wins MCADS contract to modernize CMS Claims Handling System
benzinga.com - July 11 at 1:14 AM
finance.yahoo.com logoFlexion achieves Select Tier Status within the AWS Partner Network
finance.yahoo.com - July 10 at 3:13 PM
yahoo.com logo7 Exercises to Stretch Plantar Flexion Movement
yahoo.com - June 10 at 5:59 PM
marketwatch.com logo2023-2029 Flexion Tires Market Growth Prospects and Countries Analysis | with 91 Pages
marketwatch.com - May 16 at 1:43 AM
finance.yahoo.com logoOPPO Find N2 Flip's Flexion Hinge Marks A Breakthrough In Flip Phone Experience
finance.yahoo.com - May 4 at 10:11 AM
marketwatch.com logoProne Leg Flexion Trainers Market Global Outlook and Projection till 2029
marketwatch.com - April 28 at 10:21 AM
marketwatch.com logoAbdominal Flexion Training Device Market Research & Size Analysis 2023-2028
marketwatch.com - April 12 at 6:57 PM
marketwatch.com logoProne Leg Flexion Trainers Market 2023 Huge Demand, Growth Opportunities and Expansion by 2031
marketwatch.com - April 6 at 4:41 PM
marketwatch.com logoGlobal Flexion Tires Market: Future Extrapolations and Emerging Updates for 2023-2027
marketwatch.com - March 23 at 4:51 PM
msn.com logoOppo’s new Flexion hinge has made flip phones more practical and crease minimal
msn.com - February 24 at 9:41 AM
seekingalpha.com logoPCRX Pacira BioSciences, Inc.
seekingalpha.com - September 21 at 7:09 PM
thestreet.com logoCoherus BioSciences Inc. News
thestreet.com - September 1 at 6:32 PM
venturebeat.com logoFlexion targets TikTok influencers on behalf of game developers
venturebeat.com - August 17 at 10:04 AM
thestreet.com logoBiotech Movers: Akebia Soars on Expanded Partnership With Otsuka
thestreet.com - July 2 at 12:04 AM
thestreet.com logoWhy Flexion Therapeutics (FLXN) Stock Is Plummeting in After-Hours Trading Today
thestreet.com - January 13 at 10:58 PM
marketbeat.com logo
marketbeat.com - November 19 at 6:04 AM
finance.yahoo.com logoPacira's (PCRX) Q3 Earnings Beat Estimates, Revenues Miss Mark
finance.yahoo.com - November 3 at 3:37 PM
finance.yahoo.com logoSHAREHOLDER ALERT: WeissLaw LLP Reminds DWSN, PAE, XLRN, and FLXN Shareholders About Its Ongoing Investigations
finance.yahoo.com - November 1 at 10:07 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flexion Therapeutics, Inc. - FLXN
finance.yahoo.com - October 30 at 10:43 PM
prnewswire.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flexion Therapeutics, Inc. - FLXN
prnewswire.com - October 30 at 8:14 PM
finance.yahoo.com logoEarnings Preview: Flexion Therapeutics (FLXN) Q3 Earnings Expected to Decline
finance.yahoo.com - October 27 at 6:39 PM
finance.yahoo.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ESBK, FLXN, COLB, CXP; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - October 21 at 8:53 PM
finance.yahoo.com logoSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Flexion Therapeutics, Inc. (Nasdaq - FLXN)
finance.yahoo.com - October 13 at 7:55 PM
nasdaq.com logoFlexion Therapeutics (NASDAQ:FLXN) shareholders are up 53% this past week, but still in the red over the last five years
nasdaq.com - October 13 at 8:55 AM
marketwatch.com logoFlexion Therapeutics Shares Soar on Pacira BioSciences Deal >FLXN
marketwatch.com - October 13 at 3:55 AM
businesswire.com logoFLEXION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion ...
businesswire.com - October 12 at 5:14 PM
finance.yahoo.com logoPacira Biosciences to Snap Up Flexion Therapeutics; Shares Pop
finance.yahoo.com - October 12 at 12:14 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Flexion Therapeutics, Inc. Merger
finance.yahoo.com - October 12 at 12:14 PM
markets.businessinsider.com logoMid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
markets.businessinsider.com - October 11 at 4:10 PM
businesswire.com logoFlexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Flexion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to ...
businesswire.com - October 11 at 4:10 PM
finance.yahoo.com logoFlexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Flexion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FLXN
finance.yahoo.com - October 11 at 4:10 PM
finance.yahoo.com logoShareholder Alert: Ademi LLP investigates whether Flexion Therapeutics, Inc. has obtained a Fair Price in its transaction with Pacira
finance.yahoo.com - October 11 at 4:10 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Flexion Therapeutics, Inc. with Pacira BioSciences, Inc.
finance.yahoo.com - October 11 at 4:10 PM
marketbeat.com logo
marketbeat.com - October 11 at 6:59 AM
finance.yahoo.com logoFlexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - October 1 at 7:29 PM
finance.yahoo.com logoFlexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 8 at 9:27 PM
finance.yahoo.com logoFlexion Therapeutics Announces Inclusion of ZILRETTA® in American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines for the Management of Osteoarthritis of the Knee
finance.yahoo.com - September 2 at 4:20 PM
finance.yahoo.com logoFlexion Therapeutics (FLXN) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - August 30 at 4:45 PM
finance.yahoo.com logoWhy Is Flexion Therapeutics (FLXN) Stock Gaining On Wednesday?
finance.yahoo.com - August 25 at 8:39 PM
apnews.com logoFlexion Therapeutics Announces Expansion of Phase 1b Trial Investigating FX301 for the ...
apnews.com - August 25 at 9:26 AM
finance.yahoo.com logoFlexion Therapeutics Announces Expansion of Phase 1b Trial Investigating FX301 for the Management of Post-Operative Pain
finance.yahoo.com - August 25 at 9:26 AM
finance.yahoo.com logo2 “Strong Buy” Penny Stocks That Could See 200% Gains (Or More)
finance.yahoo.com - August 18 at 5:11 PM
finance.yahoo.com logoWhy Flexion Therapeutics (FLXN) Could Be an Impressive Growth Stock
finance.yahoo.com - August 17 at 4:53 PM
finance.yahoo.com logoDown 24.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Flexion Therapeutics (FLXN)
finance.yahoo.com - August 16 at 5:29 PM
nasdaq.com logoFlexion Therapeutics, Inc.'s (NASDAQ:FLXN)) market cap declines to US$254m but insiders who sold US$604k stock were able to hedge their losses
nasdaq.com - August 14 at 4:06 PM
apnews.com logoFlexion Therapeutics Announces Publication of Results from Phase 2 Pharmacokinetics (PK) and ...
apnews.com - August 9 at 6:27 PM
finance.yahoo.com logoFlexion Therapeutics Announces Publication of Results from Phase 2 Pharmacokinetics (PK) and Safety Study of ZILRETTA® in Shoulder Osteoarthritis (OA)
finance.yahoo.com - August 9 at 6:27 PM
Get Flexion Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLXN and its competitors with MarketBeat's FREE daily newsletter.



FLXN Media Mentions By Week

FLXN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FLXN
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

FLXN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FLXN Articles
This Week

0

0

FLXN Articles
Average Week

Get Flexion Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLXN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:FLXN) was last updated on 2/21/2024 by MarketBeat.com Staff